B.Sc

Micro Labs, one of the fastest growing pharmaceutical companies in India with Global operations in over 60 countries. We enjoy a strong presence in various segments like Cardiology, Opthalmology, Psychiatry, Dermatology, Diabetology etc. with most of its brands among TOP 5 in their respective category.

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.

Flamingo Pharmaceuticals Ltd. is a quality driven pharmaceutical company with an experience of over two decades in global markets, exporting to 52 countries and having Rs.200 crores+ turnover. Flamingo has WHO-GMP/UK MHRA certified 100% EOU unit.

Cadila Pharmaceuticals Ltd. (CPL) Is one of India’s most reputed, research-based, techno-savvy pharmaceutical companies with a focus in the area of Formulations & APIs and having its Corporate Office at Bhat, Ahmedabad and State-of-art manufacturing facilities at Dholka, Ankleshwar, Kadi and Jammu accredited with USFDA, MHRA, TGA, MCA, MCC & WHO certifications.

Clinexa Life Sciences Pvt Ltd is a full-service Contract Research Organization (CRO) with extended clinical research capabilities having a distinguished investigator network throughout India offering comprehensive clinical research and site management services to Pharmaceutical and Biotechnology companies, Contract Research Organizations etc.

Inga Laboratories P. Ltd., a research-based pharmaceutical corporation, was established in 1974. The company’s activities are focused to the development, manufacture and marketing of pharmaceutical formulations at affordable prices.
Inga Laboratories P. Ltd. manufactures galenical forms such as tablets, capsules, liquid orals, injectables and beta lactum formulations in compliance with the latest current Good Manufacturing Practices.

Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.